Valeo Pharma Inc.
VPHIF
$0.0469
-$0.0471-50.11%
OTC PK
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.64M | -22.03M | -21.06M | -20.60M | -20.79M |
| Total Depreciation and Amortization | 1.84M | 1.86M | 1.85M | 1.88M | 1.67M |
| Total Amortization of Deferred Charges | 118.80K | 118.80K | 118.80K | 71.40K | 214.10K |
| Total Other Non-Cash Items | 6.70M | 4.51M | 4.30M | 4.01M | 6.50M |
| Change in Net Operating Assets | 12.10M | 11.40M | 12.69M | 3.12M | -5.50M |
| Cash from Operations | -2.87M | -4.14M | -2.09M | -11.53M | -17.91M |
| Capital Expenditure | -87.90K | -171.10K | -316.60K | -354.50K | -364.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.50M | -2.50M | -3.48M | -3.74M | 3.70M |
| Cash from Investing | -2.59M | -2.67M | -3.79M | -4.09M | 3.34M |
| Total Debt Issued | 2.75M | 4.05M | 4.05M | 3.37M | -40.39M |
| Total Debt Repaid | -1.97M | -1.79M | -1.19M | -1.03M | 3.31M |
| Issuance of Common Stock | 3.92M | 3.92M | 3.92M | 3.92M | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -271.00K | -267.00K | -227.00K | -218.00K | 38.03M |
| Cash from Financing | 3.26M | 4.37M | 4.84M | 4.46M | 712.50K |
| Foreign Exchange rate Adjustments | 252.20K | 66.90K | 37.60K | 40.30K | 499.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.95M | -2.37M | -1.01M | -11.11M | -13.36M |